NICE gears up to support World Evidence-based Healthcare Day
Inaugural World Evidence-based Healthcare (EBHC) Day takes place on Tuesday 20 October 2020
-
NICE draft guidance recommends siponimod for treating secondary progressive multiple sclerosis
NICE has today (15 October 2020) issued draft guidance which now recommends siponimod (also called Mayzent and made by Novartis) for treating secondary progressive multiple sclerosis (MS).
-
NICE non-executive director Elaine Inglesby-Burke CBE awarded Damehood for services to nursing
Elaine has been honoured in the Queen’s birthday honours list to recognise her commitment to the profession
-
NICE proposes simplifying how medicines and medical devices are selected for evaluation.
As part of the work underway to review the methods and processes NICE uses to develop guidance on medicines, medical devices and diagnostics, NICE has launched a public consultation on proposals for changing how it selects the topics it will develop guidance on.
